Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STELLAR in newly diagnosed Richter's syndrome
2017-004401-40Phase 2Unknown
- Sponsor
- University of Birmingham
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of acalabrutinib, rituximab, cyclophosphamide, doxorubicin, vincristine and 1 more in Richter's syndrome (RS) (2 arms), sponsored by University of Birmingham. Status: unknown.
02
Drugs
acalabrutinibrituximabcyclophosphamidedoxorubicinvincristine
03
Conditions
Richter's syndrome (RS)
Beyond the preview
Go deeper on 2017-004401-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004401-40.